All terms in EFO
| Label | Id | Description |
|---|---|---|
| Ataxia | HP_0001251 | [Cerebellar ataxia refers to ataxia due to dysfunction of the cerebellum. This causes a variety of elementary neurological deficits including asynergy (lack of coordination between muscles, limbs and joints), dysmetria (lack of ability to judge distances that can lead to under- or overshoot in grasping movements), and dysdiadochokinesia (inability to perform rapid movements requiring antagonizing muscle groups to be switched on and off repeatedly).] |
| N-acylethanolamine-hydrolyzing acid amidase measurement | EFO_0008240 | [quantification of the amount of N-acylethanolamine-hydrolyzing acid amidase in a sample] |
| Abnormal muscle tone | HP_0003808 | |
| NAD-dependent protein deacetylase sirtuin-2 measurement | EFO_0008241 | [quantification of the amount of NAD-dependent protein deacetylase sirtuin-2 in a sample] |
| neurogenic locus notch homolog protein 1 measurement | EFO_0008246 | [quantification of the amount of neurogenic locus notch homolog protein 1 in a sample] |
| Hordeum vulgare | NCBITaxon_4513 | |
| neutral ceramidase measurement | EFO_0008247 | [quantification of the amount of neutral ceramidase in a sample] |
| neutrophil collagenase measurement | EFO_0008248 | [quantification of the amount of neutrophil collagenase in a sample] |
| nidogen-1 measurement | EFO_0008249 | [quantification of the amount of nidogen-1 in a sample] |
| NADPH--cytochrome P450 reductase measurement | EFO_0008242 | [quantification of the amount of NADPH--cytochrome P450 reductase in a sample] |
| natural cytotoxicity triggering receptor 3 measurement | EFO_0008243 | [quantification of the amount of natural cytotoxicity triggering receptor 3 in a sample] |
| neurexophilin-1 measurement | EFO_0008244 | [quantification of the amount of neurexophilin-1 in a sample] |
| Gamstorp-Wohlfart syndrome | MONDO_0007646 | [Autosomal recessive axonal neuropathy with neuromyotonia is a rare peripheral neuropathy characterized by slowly progressive axonal, motor greater than sensory polyneuropathy combined with neuromytonia (including spontaneous muscular activity at rest (myokymia), impaired muscle relaxation (pseudomyotonia), and contractures of hands and feet) and neuromyotonic or myokymic discharges on needle EMG. It presents with distal lower limb weakness with gait impairment, muscle stiffness, fasciculations and cramps in hands and legs worsened by cold, decreased to absent tendon reflexes, intrinsic hand muscle atrophy and, variably, mild distal sensory impairment.] |
| X-09108 measurement | EFO_0021209 | [Quantification of the amount of X-09108 in a sample.] |
| aristolochic acid | CHEBI_2825 | |
| X-08766 measurement | EFO_0021206 | [Quantification of the amount of X-08766 in a sample.] |
| Sorsby fundus dystrophy | MONDO_0007640 | [A rare progressive autosomal dominant macular dystrophy, presenting between the third and sixth decades of life, characterized by retinal atrophy and retinal detachment and leading to loss of central vision, then peripheral vision, and eventually blindness.] |
| X-08402 measurement | EFO_0021205 | [Quantification of the amount of X-08402 in a sample.] |
| X-09026 measurement | EFO_0021208 | [Quantification of the amount of X-09026 in a sample.] |
| X-08988 measurement | EFO_0021207 | [Quantification of the amount of X-08988 in a sample.] |